Emalex Biosciences Inc.

Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder

Role: lead

Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

Role: lead

A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

Role: lead

Food-effect Study of Ecopipam Pharmacokinetics

Role: lead

Drug Interaction Study

Role: lead

Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble

Role: lead

Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease

Role: lead

Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam

Role: lead

Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years

Role: lead

Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension

Role: lead

Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents

Role: lead

Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization

Role: lead

Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport

Role: lead

Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)

Role: lead

Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects

Role: lead

Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite

Role: lead

Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates

Role: lead